Cardiac ischemia–reperfusion injury under insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-induced obesity

BACKGROUND: Recent large-scale clinical trials have shown that SGLT2-inhibitors reduce cardiovascular events in diabetic patients. However, the regulation and functional role of cardiac sodium–glucose cotransporter (SGLT1 is the dominant isoform) compared with those of other glucose transporters (in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cardiovasc Diabetol
Main Authors: Yoshii, Akira, Nagoshi, Tomohisa, Kashiwagi, Yusuke, Kimura, Haruka, Tanaka, Yoshiro, Oi, Yuhei, Ito, Keiichi, Yoshino, Takuya, Tanaka, Toshikazu D., Yoshimura, Michihiro
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6604374/
https://ncbi.nlm.nih.gov/pubmed/31262297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-019-0889-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados